Greg is a partner at Menlo Ventures, where he invests in teams trying to solve major problems in life science and healthcare, with a special interest in novel therapeutic platforms, digital health, and transformative technologies. Since joining in 2017, Greg has led Menlo’s investments in Clear Labs, Delfi Diagnostics, Encoded Therapeutics, Epiodyne, Genesis Therapeutics, H1 Insights, Ophelia Health, Particle Health, Pliant Therapeutics (NASDAQ: PLRX), Senti Biosciences, Scribe Therapeutics and Riva Health. He has also been involved in investments in Benchling, Recursion Pharmaceuticals, and Cofactor Genomics.
Location
Palo Alto, California
Notable investments
Check size range(s)
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Rounds their fund invests in
Seed
Series A
Series B+
Rounds their fund leads
Seed
Sectors their fund invests in
Biotech
Consumer
Cybersecurity
Fintech
Health
Logistics
Enterprise
Geographies their fund invests in
USA
Browse through a massive startup database
Browse Harmonic, our favorite resource for parsing through the world's startup data.
Partner
Learn more about Harmonic
No items found.
No colleagues here yet.
Funds they're a part of
Menlo Ventures
About the Fund
46 year old VC firm with >$5bn AUM investing in innovation-driven companies.
View Profile
Their Colleagues
Sheets Their fund(s) are in
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Related Investors
Round-focused Sheets
Geography-focused Sheets
Sector-focused Sheets
